Global antibiotics and antimycotics market to reach $91.54 billion by 2031, driven by infectious diseases

From GlobeNewswire: 2024-11-29 07:24:00

The global antibiotics and antimycotics market is seeing significant growth due to rising infectious diseases and ongoing research and funding. Market analysis shows a variety of drugs used for bacterial and fungal infections will drive market growth. The market is expected to reach $91.54 billion by 2031, with a CAGR of 5.2%.

Infectious diseases cause 77 million deaths annually, with TB being a significant concern. Fungal infections affect millions yearly. Companies like F2G and GARDP are developing new drugs. Geographically, North America leads the market. The market faces challenges, but collaborations are driving innovation.

The market is segmented by drug class, indication, route of administration, and distribution channel. Penicillins hold the largest market share. Companies like Pfizer and Novartis are key players. Strategic collaborations and innovations are essential for combating infectious diseases and promoting public health.



Read more at GlobeNewswire: Antibiotics and Antimycotics Market Size to Hit $91.54